Pharmaron Beijing Co., Ltd. (SHE:300759)
28.39
-0.74 (-2.54%)
Nov 21, 2025, 3:07 PM CST
Pharmaron Beijing Revenue
Pharmaron Beijing had revenue of 3.64B CNY in the quarter ending September 30, 2025, with 13.44% growth. This brings the company's revenue in the last twelve months to 13.54B, up 14.83% year-over-year. In the year 2024, Pharmaron Beijing had annual revenue of 12.28B with 6.39% growth.
Revenue (ttm)
13.54B
Revenue Growth
+14.83%
P/S Ratio
3.51
Revenue / Employee
633.79K
Employees
21,370
Market Cap
47.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.28B | 737.78M | 6.39% |
| Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
| Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
| Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
| Dec 31, 2020 | 5.13B | 1.38B | 36.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |
| Shanghai United Imaging Healthcare | 12.20B |